Disruption studies of a candida albicans gene, ELF1: A member of the ATP-binding cassette family

Microbiology

Volumn 144, Issue 8, 1998, Pages 2311-2321

  Sturtevant, Joy ^a   Cihlar, Ronald ^a   Calderone, Richard ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ATP binding cassette gene; Candida albicans; Gene disruption

Indexed keywords

ELONGATION FACTOR 1; ELONGATION FACTOR 3;

ARTICLE; CANDIDA ALBICANS; FUNGAL GENETICS; GENE DISRUPTION; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

CANDIDA ALBICANS;

EID: 0031716416     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/00221287-144-8-2311     Document Type: Article

References (39)

1. Altschul. S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. (1990). Basic local alignment search tool. J Mol Biol 215, 403-410.
2. Balzi, E. & Goffeau, A. (1994). Genetics and biochemistry of yeast multidrug resistance. Biochim Biophys Acta 1187, 152-162.
3. Boeke, J. D., LaCroute, F. & Fink, G. R. (1984). A positive selection for mutants lacking orotidine-5'-phosphate decarboxylase activity in yeast : 5-fluoroorotic acid resistance. Mol Gen Genet 197, 345-346.
4. Calderone, R. A., Southard, S. & Hale, C. (1992). The complement C3d-binding receptor (CR2) of Candida albicans: cloning and sequence analysis of a gene fragment homologous with a human CR2 cDNA clone. In Molecular Biology and its Application to Medical Mycology, pp. 23-30. Edited by B. Maresca, G. S. Kobayashi & H. Yamaguchi. Taoromina, Italy : Springer (NATO ASI Series).
5. Chakraburtty, K., Ziehler, J., Sharma, N. & Hopkins, A. S. (1995). Elongation factor 3: a new target for antifungal drugs. In Morphogenesis and Metabolism in Opportunistic Fungal Pathogens, pp. 324-331. Edited by J.-P. Latgé, R. Calderone, & H. Yamaguchi.
6. Colthurst, D. R., Schauder, B. S., Hayes, M. V. & Tuite, M. F. (1992). Elongation factor 3 (EF-3) from Candida albicans shows both structural and functional similarity to EF-3 from Saccharomyces cerevisiae. Mol Microbiol 6, 1025-1033.
7. Devereux, J., Haeberli, P. & Smithies, O. (1984). A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res 12, 387-395.
8. Fling, M. E., Kopf, J., Tamarkin, A., Gorman, J. A., Smith, H. A. & Koltin, Y. (1991). Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol Gen Genet 227, 318-329.
9. Fonzi, W. A. & Irwin, M. Y. (1993). Isogenic strain construction and gene mapping in Candida albicans. Genetics 134, 717-728.
10. Gietz. D., St. Jean, A., Woods. R. A. & Schiestl, R. H. (1992). Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res 20, 1425.
11. Gillum. A. M., Tsay, E. Y. H. & Kirsch, D. R. (1984). Isolation of the Candida albicans gene for orotidine-5′ phosphate decarboxylase by complementation of Saccharomyces cerevisiae ura3 and Escherichia coli pyrF mutations. Mol Gen Genet 198, 179-182.
12. Gottesman, M. M. & Pastan, I. (1993). Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62, 385-427.
13. Hawser, S. P. & Douglas, L. J. (1994). Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 62, 915-921.
14. Higgins, C. F. (1992). ABC transporters: from microorganisms to man. Annu Rev Cell Biol 8, 67-113.
15. McCullogh, M. & Hume, S. (1995). A longitudinal study of the change in resistance pattern and genetic relationship of oral Candida albicans from HIV-infected patients. J Med Vet Mycol 33, 33-37.
16. Manning, M. & Mitchell, T. G. (1980). Strain variation and morphogenesis of yeast and mycelial-phase Candida albicans in low sulfate, synthetic medium. J Bacteriol 142, 717-719.
17. Matthews, R. C. (1994). Pathogenicity determinants of Candida albicans: potential targets for immunotherapy? Microbiology 140, 1505-1511.
18. Monod, M., Togni, G., Hube, B. & Sanglard, D. (1994). Multiplicity of genes encoding secreted aspartic proteinases in Candida species. Mol Microbiol 13, 357-368.
19. Moore, M. M., Cooper, N. R., Tack, B. F. & Nemerow, G. F. (1987). Molecular cloning of the cDNA encoding the Epstein-Barr virus C3d receptor (complement receptor type 2) of human B lymphocytes. Proc Natl Acad Sci USA 84, 9194-9198.
20. National Committee for Clinical Laboratory Standards. (1995). Reference method for broth dilution antifungal susceptibility testing of yeasts. Tentative standard. NCCLS document M27-T 15(10). Wayne PA: National Committee for Laboratory Standards.
21. Pfaller, M. A., Rhine-Chalberg, J., Redding, S. W., Smith, J., Farinacci. G., Fothergill, A. W. & Rinaldi, M. G. (1994). Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol 32, 59-64.
22. Philippsen, P., Stotz, A. & Scherf, C. (1991). DNA of Saccharomyces cerevisiae. Methods Enzymol 194, 169-182.
23. Qin, S., Xie, A., Bonato, M. C. M. & McLaughlin, C. S. (1990). Sequence analysis of the translational elongation factor 3 from Saccharomyces cerevisiae. J Biol Chem 265, 1903-1912.
24. Sambrook, J., Frrtsch, E. F. & Maniatis, T. (1989). Molecular Cloning: a Labarotory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
25. Sangeorzan, J. A., Bradley, S. F., He, X., Zarins, L. T., Ridenour, G. L., Tiballi, R. N. & Kauffman, C. A. (1994). Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment and emergence of fluconazole resistance. Am J Med 97, 339-346.
26. Sanger, F., Nicklen, S. & Coulson, A. R. (1977). DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci, USA 74, 5463-5467.
27. Sanglard, D., Kuchler, K., lscher, F., Pagani, J. L., Monod, M. & Bille, J. (1995). Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 39, 2378-2386.
28. Sanglard, D., lscher, F., Monod, M. & Bille, J. (1996). Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolite inhibitors. Antimicrob Agents Chemother 40, 2300-2305.
29. Sanglard, D., lscher, F., Monod, M. & Bille, J. (1997). Cloning of Candida albicans genes conferring resistance to azole antifungal agents : characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143, 405-416.
30. Saxena, A. & Calderone, R. (1990). Purification and characterization of the extracellular C3d-binding protein of Candida albicans. Infect Immun 56, 309-314.
31. Shepherd, M. G., Yin, C. Y., Ram, S. P. & Sullivan, P. A. (1980). Germ tube induction in Candida albicans. Can J Microbiol 26, 21-26.
32. Sherman, F., Fink, G. R. & Hicks, J. B. (1986). Methods in Yeast Genetics, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
33. Silver, J. (1992). Inverse polymerase chain reaction. In PCR: a Practical Approach, pp. 137-146. Edited by M. J. McPherson, P. Quirke & G. R. Taylor. Oxford : Oxford University Press.
34. Titus, D. E. (1991). Promega Protocols and Applications Guide, 2nd edn. Madison, WI : Promega.
35. Vazquez de Aldana, C. R., Marton, M. J. & Hinnebusch, A. J. (1995). GCN20, a novel ATP-binding cassette protein, and GCN1 reside in a complex that mediates activation of the eIF-2α kinase GCN2 in amino acid-starved cells. EMBO J 14, 3184-3199.
36. White, T. (1997). Increased mRNA levels of ERG16, CDR1 and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 41, 1482-1487.
37. Wickes, B. L., Golin, E. J. & Kwon-Chung, K.-J. (1991a). Chromosomal rearangement in Candida stellatoidea results in a positive effect on phenotype. Infect Immun 59, 1762-1771.
38. Wickes, B. L., Staudinger, J., Magee, B. B., Kwon-Chung. K.-J., Magee, P. T. & Scherer, S. (1991b). Physical and genetic mapping of Candida albicans: several genes previously assigned to chromosome 1 map to chromosome R, the rDNA-containing linkage group. Infect Immun 59, 2480-2484.
39. Ypma-Wong, M. F., Fonzi, W. A. & Sypherd, P. S. (1992). Fungal specific translation factor 3 gene present in Pneumocystis carinii. Infect Immun 60, 4140-4145.